Companies: 10,795·Total market cap: $144.5T
InterCure Ltd.

InterCure Ltd.

INCRNASDAQHealthcare● Active
$0.99
$-0.03(-2.94%)
Market Cap$54134522
P/E Ratio—
52W High$1.77
52W Low$0.68
Overview
Stock ranking:Drug Manufacturers - Specialty & Generic·Healthcare·View All Market Cap Rankings →

InterCure Ltd. (INCR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · INCR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-1.61incr eps ttm · incr earnings per shareEarnings history
PE Ratio (TTM)—incr pe ratio ttm · incr price to earningsPE Ratio deep dive
Revenue (TTM)$243.1Mincr revenue ttm · incr annual revenueFull revenue history
Dividend YieldNo Dividenddoes incr pay dividends · incr dividend yieldDividend history
Shares Outstanding56.8Mincr shares outstanding · incr floatShares outstanding history
Next EarningsTBAincr earnings date · incr next earningsEarnings history

Explore InterCure Ltd. Data

incr stock data · financials
Market Cap$54.1Mincr market cap · incr valuation
Analyst Forecast$— · Buy
DividendsNo Dividenddoes intercure ltd. pay dividends · incr dividend yield
Revenue$270.2M+13.13%intercure ltd. annual revenue · incr revenue
EarningsEPS $-0.63+55.63%incr earnings · incr eps
PE Ratio—incr pe ratio · incr price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$270.2M▲ +13.13% YoY
202320242025
intercure ltd. revenue · incr revenue 2025
FY 2025Net Income-$35.7M▲ +47.33% YoY
202320242025
intercure ltd. net income · incr profit 2025
FY 2025EPS$-0.63▲ +55.63% YoY
202320242025
incr eps · intercure ltd. earnings per share 2025
TTM:Revenue: $243.1MNet Income: -$70.9MEPS: $-1.61View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy1 analystsis incr a buy · incr analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.99Current
$—Avg Target
$—High
incr price target · incr 12 month forecast

Total: 1 · Buy rate: 100.0%

Stock Performance

Full History
1D-2.94%
1W-3.88%
1M+18.03%
3M+20.70%
YTD+8.79%
1Y-34.87%
5Y-87.47%

About InterCure Ltd.

CEOAlexander Rabinovich
IPO DateJan 28, 2019
Employees320
CountryIL
Websiteintercure.co

InterCure Ltd. including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturin…

Drug Manufacturers - Specialty & GenericHealthcareNASDAQIL

what is intercure ltd. · incr stock overview · intercure ltd. company profile · who is intercure ltd. ceo · incr NASDAQ · intercure ltd. headquarters · intercure ltd. business segments

About Stock Overview & Key Data

InterCure Ltd. (INCR) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on NASDAQ since Jan 28, 2019. As of the latest trading session, INCR stock price is $0.99, with a market capitalization of $54.1M. The stock has returned -34.87% over the past 12 months and +8.79% year-to-date.

According to 1 Wall Street analysts, the consensus rating for InterCure Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, InterCure Ltd. reported revenue of $270.2M and net income of -$35.7M. For detailed data — including InterCure Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, InterCure Ltd. (INCR) stock price is $0.99. The stock is traded on NASDAQ under the ticker symbol INCR. The 52-week range is $0.68 – $1.77.

INCR stock priceINCR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice